336 related articles for article (PubMed ID: 36632072)
1. l-carnitine: Nutrition, pathology, and health benefits.
Alhasaniah AH
Saudi J Biol Sci; 2023 Feb; 30(2):103555. PubMed ID: 36632072
[TBL] [Abstract][Full Text] [Related]
2. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.
Goa KL; Brogden RN
Drugs; 1987 Jul; 34(1):1-24. PubMed ID: 3308409
[TBL] [Abstract][Full Text] [Related]
3. Role of carnitine in disease.
Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
Nutr Metab (Lond); 2010 Apr; 7():30. PubMed ID: 20398344
[TBL] [Abstract][Full Text] [Related]
4. Biomedical role of L-carnitine in several organ systems, cellular tissues, and COVID-19.
Al-Dhuayan IS
Braz J Biol; 2023; 82():e267633. PubMed ID: 36629544
[TBL] [Abstract][Full Text] [Related]
5. Carnitine metabolism and deficit--when supplementation is necessary?
Evangeliou A; Vlassopoulos D
Curr Pharm Biotechnol; 2003 Jun; 4(3):211-9. PubMed ID: 12769764
[TBL] [Abstract][Full Text] [Related]
6. [L-carnitine: metabolism, functions and value in pathology].
Jacob C; Belleville F
Pathol Biol (Paris); 1992 Nov; 40(9):910-9. PubMed ID: 1296165
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia.
Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Aleksandrowicz-Wrona E; Jankun J; Lysiak-Szydłowska W
Oncol Rep; 2012 Jul; 28(1):319-23. PubMed ID: 22562434
[TBL] [Abstract][Full Text] [Related]
8. [Carnitine: physiologic role, primary and secondary deficiency].
Jusić A
Lijec Vjesn; 1992; 114(5-8):166-71. PubMed ID: 1343053
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
10. L-Carnitine counteracts in vitro fructose-induced hepatic steatosis through targeting oxidative stress markers.
Montesano A; Senesi P; Vacante F; Mollica G; Benedini S; Mariotti M; Luzi L; Terruzzi I
J Endocrinol Invest; 2020 Apr; 43(4):493-503. PubMed ID: 31705397
[TBL] [Abstract][Full Text] [Related]
11. Carnitine: an overview of its role in preventive medicine.
Kendler BS
Prev Med; 1986 Jul; 15(4):373-90. PubMed ID: 3532087
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment for carnitine.
Hathcock JN; Shao A
Regul Toxicol Pharmacol; 2006 Oct; 46(1):23-8. PubMed ID: 16901595
[TBL] [Abstract][Full Text] [Related]
13. L-carnitine and cancer cachexia. II. Effects of lipid emulsion used in total parenteral nutrition on parameters of hemostasis and inflammatory state in L-carnitine deficiency in myocytes.
Szefel J; Kruszewski WJ; Ciesielski M; Szajewski M; Kawecki K; Jankun J; Lysiak-Szydłowska W
Oncol Rep; 2012 Jul; 28(1):324-9. PubMed ID: 22562458
[TBL] [Abstract][Full Text] [Related]
14. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
15. The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients.
Katalinic L; Krtalic B; Jelakovic B; Basic-Jukic N
Kidney Blood Press Res; 2018; 43(4):1113-1120. PubMed ID: 30016788
[TBL] [Abstract][Full Text] [Related]
16. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
Ribas GS; Vargas CR; Wajner M
Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
[TBL] [Abstract][Full Text] [Related]
17. History of L-carnitine: implications for renal disease.
Matera M; Bellinghieri G; Costantino G; Santoro D; Calvani M; Savica V
J Ren Nutr; 2003 Jan; 13(1):2-14. PubMed ID: 12563618
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet.
Glasgow AM; Engel AG; Bier DM; Perry LW; Dickie M; Todaro J; Brown BI; Utter MF
Pediatr Res; 1983 May; 17(5):319-26. PubMed ID: 6682967
[TBL] [Abstract][Full Text] [Related]
19. Primary carnitine deficiency in two sisters with intractable epilepsy and reversible metabolic cardiomyopathy: Two case reports.
Yang XF; Liu GS; Yi B
Exp Ther Med; 2020 Nov; 20(5):118. PubMed ID: 33005244
[TBL] [Abstract][Full Text] [Related]
20. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
